Breaking News

Marken Names CFO

May 1, 2014

Menzies brings 26 years of senior operational and finance experience

Steve J. Menzies bas been appointed chief financial officer and board director at Marken Group. He succeeds Alan Gullan who stepped down from the role on April 30.
 
Mr. Menzies has 26 years of senior operational and board level finance experience, most recently as interim chief financial officer for IMI plc's TA Hydronics business in Sweden. Previously he served as chief financial officer and senior vice president, Operational Excellence for First Data Corp.'s International reporting segment, with responsibility for EMEA, APAC and Latin America & Canada. 
 
"I am delighted to welcome Steve to Marken," said Wes Wheeler, Marken's chief executive officer, "Steve brings to us a wealth of international finance experience and leadership.  He has an outstanding track record leading transformational change, delivering profitable double-digit growth, managing process improvements, and streamlining financial management in multinational public and private equity-owned companies.  We look forward to leveraging all of Steve's formidable skills over the coming years."
 
blog comments powered by Disqus
  • Flexible Manufacturing Strategies

    Kristin Brooks, Contract Pharma||April 4, 2016
    Michael Lehmann of Patheon discusses solutions for pharmaceutical forecasting errors

  • Platinum Press Facility Tour

    Platinum Press Facility Tour

    Kristin Brooks, Contract Pharma||March 23, 2016
    Opens doors to new, 47,000-sq.-ft. packaging facility in Oakland, NJ

  • Biopharma Packaging Equipment Close-up

    Biopharma Packaging Equipment Close-up

    Kristin Brooks, Contract Pharma||March 7, 2016
    Sieghard Schuchmann of OPTIMA discusses biopharma trends impacting packaging equipment, and the latest capabilities

  • Fit-For-Purpose Assay Development in Bioanalysis

    Fit-For-Purpose Assay Development in Bioanalysis

    Franklin Spriggs, Ligand Binding Assay Group Leader; Ashley Brant, Program Manager, AIT Bioscience||January 28, 2016
    The success of bioanalytical studies relies on the selection of the most suitable analytical method but the timeline of method development and types of analyses involved vary greatly.

  • Getting Real

    Michael Pollock, PPD||November 17, 2015
    Partnering for clinical and real-world evidence studies

  • Bringing Transparency and Collaboration to CRO Oversight

    Bringing Transparency and Collaboration to CRO Oversight

    Craig Morgan , goBalto Inc. ||November 17, 2015
    Relationships between sponsors and CROs are getting stronger